VacV Biotech

London, United Kingdom

VacV Biotech develops an oncolytic virus platform based on the vaccinia virus.

$3.0M raised

Jan 2022

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has VacV Biotech raised?

VacV Biotech has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in January 2022.

Who are VacV Biotech's investors?

VacV Biotech's investors include Prox Ventures.

Where is VacV Biotech headquartered?

VacV Biotech is headquartered in London, United Kingdom.

What does VacV Biotech do?

VacV Biotech develops an oncolytic virus platform based on the vaccinia virus.

What stage is VacV Biotech at?

VacV Biotech is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2022.

MLA

"VacV Biotech — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/vacv-biotech. Accessed July 3, 2026.

APA

VCBacked. (2022). VacV Biotech — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/vacv-biotech

Wikipedia (cite web)

{{cite web |title=VacV Biotech — Funding & Investors |url=https://www.vcbacked.co/company/vacv-biotech |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2022.